CannBioRx Life Sciences (ATNFW) has had the highest return this quarter by a US stock, returning 5,143.9%.

ASSET	QUARTER	% RETURN
CannBioRx Life Sciences (ATNFW)	Q3 2025	5,143.9%
Zepp Health (ZEPP)	Q3 2025	1,149.45%
Triumph (TGI)	Q3 2025	1,034.08%
Rich Sparkle Holdings Limited Ordinary Shares (ANPA)	Q3 2025	913.89%
Imunon (IMNN)	Q3 2025	820.07%
Abivax SA American Depositary Shares (ABVX)	Q3 2025	799.62%
180 Life Sciences (ATNF)	Q3 2025	656.99%
BT Brands Inc Warrant (BTBDW)	Q3 2025	640.74%
CEA Industries (BNCWW)	Q3 2025	602.7%
Lixte Biotechnology (LIXTW)	Q3 2025	545.16%
Aureus Greenway Holdings Inc Common Stock (AGH)	Q3 2025	535.09%
Newegg Commerce (NEGG)	Q3 2025	526.29%
Dynamix Corporation Warrant (DYNXW)	Q3 2025	516.5%
Opendoor Technologies (OPEN)	Q3 2025	492.52%
Cognition Therapeutics (CGTX)	Q3 2025	392.01%
CEA Industries (VAPEW)	Q3 2025	386.49%
Jyong Biotech Ltd Ordinary Shares (MENS)	Q3 2025	381.08%
Connexa Sports Technologies (YYAI)	Q3 2025	372.1%
Advent Technologies (ADNWW)	Q3 2025	352.73%
Scilex (SCLXW)	Q3 2025	340.73%
Elong Power Holding Limited Class A Ordinary Shares (ELPW)	Q3 2025	326.73%
Airnet Technology (ANTE)	Q3 2025	309.09%
ProKidney (PROK)	Q3 2025	306.9%
Mill City Ventures III (MCVT)	Q3 2025	305.56%
Health In Tech, Inc Class A Common Stock (HIT)	Q3 2025	291.11%